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ABSTRACT
Introduction: Lipohypertrophy is one of the most common complications of insulin injection. Early detection of lipo-
hypertrophy is very important to prevent the risk of hyperglycemia or hypoglycemia, arisen due to inconsistencies in 
absorption of insulin. The purpose of this study is to determine the prevalence of lipohyperthrophy in insulin-treated 
type 2 Diabetes Mellitus. Methods: This is a quantitative descriptive study which was carried out from June to August 
2017 in one of tertiary hospital in Sabah. Participants were recruited via purposive convenience sampling. This study 
was divided into 2 parts which includes questionnaire survey and examination of lipohyperthrophy based on inspec-
tion and palpation techniques. Study participants were patients with type 2 Diabetes Mellitus and on insulin injection 
more than 3 months. The finding of the injection site examination recorded as “presence” and “not presence” based 
on the features of lipohyperthrophy. The features of lipohyperthrophy include a palpable lump, swelling of fatty 
tissue around the subcutaneous insulin injection site, thickened ‘rubbery’ swelling of tissue that is soft and firm, and 
less pain sensation. Respondent who have one or more of these features considered as presence of lipohyperthrophy. 
Results: Out of 130 patients, more than half of respondents (51.5%, n=67) had lipohyperthrophy and 48.5% (n=63) 
without lipohyperthrophy. The occurrence of lipohyhertrophy is shown to be higher in patients who had a longer 
duration of insulin injection (p=0.002), Failure of changing needle (p=0.026) and failure of rotation injection site 
(p=0.017) at each time of injection. Conclusion: The high prevalence of lipohypertrophy shown in this study high-
lights the need for prevention strategies, which include regular assessment for the presence of lipohypertrophy and 
health education on insulin injection. Health education should emphasize on self-assessment of lipohypertrophy, 
and the importance of right injection techniques.
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